- Home
- ZLAB vs HBANL Comparison
ZLAB vs HBANL Comparison
Compare ZLAB & HBANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | HBANL |
|---|---|---|
| Founded | 2013 | N/A |
| Country | China | United States |
| Employees | N/A | 20242 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | N/A |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZLAB | HBANL |
|---|---|---|
| Price | $18.07 | $25.53 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $57.22 | N/A |
| AVG Volume (30 Days) | ★ 937.7K | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $441,629,000.00 | N/A |
| Revenue This Year | $26.16 | N/A |
| Revenue Next Year | $30.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | N/A |
| 52 Week Low | $16.82 | N/A |
| 52 Week High | $44.34 | N/A |
Technical Indicators
Market Signals| Indicator | ZLAB | HBANL |
|---|---|---|
| Relative Strength Index (RSI) | 38.81 | 49.89 |
| Support Level | $17.37 | $25.35 |
| Resistance Level | $19.01 | $25.98 |
| Average True Range (ATR) | 0.63 | 0.21 |
| MACD | 0.30 | -0.02 |
| Stochastic Oscillator | 49.29 | 43.65 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About HBANL Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Huntington is a regional US bank with around $208 billion in assets and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.